消癌平注射液联合TP方案治疗晚期非小细胞肺癌临床观察

目的:观察消癌平注射液联合TP方案治疗晚期非小细胞肺癌(NSCLC)的临床疗效。方法:78例晚期NSCLC患者随机分为对照组和治疗组。对照组:紫杉醇135mg/m2,第1天,静脉滴注,顺铂30mg/m2,第1天～第3天,静脉滴注(TP方案);治疗组:消癌平注射液联合TP方案,两组病例的临床资料具有可比性。均每21d为1个治疗周期。结果:治疗组在近期疗效、生活质量方面均优于对照组,差异有统计学意义(P<0.05);治疗组毒副反应略低。结论:消癌平注射液联合TP方案治疗晚期NSCLC的疗效较好,可有效改善临床症状,提高生存质量及降低不良反应。

Effect of xiaoaiping injection combined with TP regimen in the treatment of advanced non-small cell lung cancer

Objective:To observe the curative effect of xiaoaiping injection combined with TP regimen in treatment of advanced non-small celllung cancer(NSCLC).Methods:Seventy-night patients with terminal NSCLC patients were divided into the control group and the treatment group.The control group:paclitaxel 135 mg/m2,the 1st day intravenous drip,cisplatin 30 mg/m2,the 1st day~3rd day,intravenous drip(TP regimen).The treatment group:xiaoaiping injection combined with TP regimen.The clinical data of two groups was comparable.Every 21 days for a treatment cycle.Results:The short-term curative effect,life quality in treatment group is better than the control group.There was statistical significance(P<0.05).The adverse effect of treatment group was slightly lower.Conclusion:Xiaoaiping injection incombination with TP regimen in treatment of non-small cell lung cancer has better efficacy,effectively improves the clinical symptoms and improves quality of life and less adverse reaction.